MEDI 20-Discovery and characterization of allosteric inhibitors of Bcr-Abl kinase

被引：0
|
作者：
Gray, Nathanael S. [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2008年 / 236卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
20-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of structure and biophysics in the discovery of allosteric kinase inhibitors: ABL001, a potent and specific inhibitor of BCR-ABL
    Cowan-Jacob, Sandra W.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2016, 72 : S4 - S5
  • [2] Discovery of Allosteric Bcr-Abl Inhibitors from Phenotypic Screen to Clinical Candidate
    Gray, Nathanael S.
    Fabbro, Doriano
    [J]. PROTEIN KINASE INHIBITORS IN RESEARCH AND MEDICINE, 2014, 548 : 173 - 188
  • [3] Discovery and characterization of novel potent BCR-ABL degraders by conjugating allosteric inhibitor
    Liu, Haixia
    Mi, Qianglong
    Ding, Xinyu
    Lin, Chencen
    Liu, Linyi
    Ren, Chaowei
    Shen, ShuTing
    Shao, YuBao
    Chen, Jinju
    Zhou, Yongqi
    Ji, Liting
    Zhang, Heqiao
    Bai, Fang
    Yang, Xiaobao
    Yin, Qianqian
    Jiang, Biao
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 244
  • [4] Allosteric inhibitors of Bcr-abl–dependent cell proliferation
    Francisco J Adrián
    Qiang Ding
    Taebo Sim
    Anastasia Velentza
    Christine Sloan
    Yi Liu
    Guobao Zhang
    Wooyoung Hur
    Sheng Ding
    Paul Manley
    Jürgen Mestan
    Doriano Fabbro
    Nathanael S Gray
    [J]. Nature Chemical Biology, 2006, 2 : 95 - 102
  • [5] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Afsar Ali Mian
    Anna Metodieva
    Susanne Badura
    Mamduh Khateb
    Nili Ruimi
    Yousef Najajreh
    Oliver Gerhard Ottmann
    Jamal Mahajna
    Martin Ruthardt
    [J]. BMC Cancer, 12
  • [6] Mechanisms of Resistance to BCR-ABL Kinase Inhibitors
    Diamond, Joana
    da Silva, Maria Gomes
    [J]. ACTA MEDICA PORTUGUESA, 2013, 26 (04): : 402 - 408
  • [7] Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
    Mian, Afsar Ali
    Metodieva, Anna
    Badura, Susanne
    Khateb, Mamduh
    Ruimi, Nili
    Najajreh, Yousef
    Ottmann, Oliver Gerhard
    Mahajna, Jamal
    Ruthardt, Martin
    [J]. BMC CANCER, 2012, 12
  • [8] Allosteric inhibition of BCR-ABL
    Hassan, A. Quamrul
    Sharma, Sreenath V.
    Warmuth, Markus
    [J]. CELL CYCLE, 2010, 9 (18) : 3710 - 3714
  • [9] The background, discovery and clinical development of BCR-ABL inhibitors
    Lambert, Gemma K.
    Duhme-Klair, Anne-Kathrin
    Morgan, Trevor
    Ramjee, Manoj K.
    [J]. DRUG DISCOVERY TODAY, 2013, 18 (19-20) : 992 - 1000
  • [10] Mechanisms of resistance to BCR-ABL and other kinase inhibitors
    Lamontanara, Allan Joaquim
    Gencer, Emel Basak
    Kuzyk, Orest
    Hantschel, Oliver
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (07): : 1449 - 1459
12345